Fred Middleton
Managing Director · Sanderling Ventures
Managing DirectorSan Mateo, CA
Fred Middleton is a Managing Director at Sanderling Ventures, which he joined in 1987 as a General Partner, with over thirty years of experience in biotechnology and biomedicine as an operator and institutional venture investor. He was the third member of Genentech's original management team from 1978, serving as its first CFO and managing the biotech industry's first IPO in 1980, and in 1984 founded Morgan Stanley Ventures. At Sanderling he has worked as investor, management team member and director in over 20 new biomedical ventures since 1988.
Board seats
105 current
· PUBLIC SOURCES
Credited hits
2
· PUBLIC SOURCES
Midas years
LAST CHECKED NOV 2026
Founder rating
LAST CHECKED NOV 2026
Maintained from public sources. Not claimed. If you're Fred Middleton, you can claim this profile.
Claim this profileHow claiming worksClaiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.
Track record
- Regeneron Pharmaceuticalsipo
Sanderling bio: Middleton served as an early stage investor and director of Regeneron Pharmaceuticals (NASDAQ: REGN)
Source: sanderling.com
- Endocyteipo
Sanderling bio: Middleton served as an early stage investor and director of Endocyte (NASDAQ: ECYT)
Source: sanderling.com
Board seats
Current board seats · 5
- Pacira PharmaceuticalsSource: sanderling.com
- StereotaxisSource: sanderling.com
- ViaCyteSource: sanderling.com
- Altor BioScienceSource: sanderling.com
- Altor BiosciencesSource: sanderling.com
Former board seats · 5
- Regeneron PharmaceuticalsSource: sanderling.com
- CardioNetSource: sanderling.com
- EndocyteSource: sanderling.com
- LineaGenSource: sanderling.com
- ActimisSource: sanderling.com
Success signals
Forbes Midas List
No public record
Not listed.
Reputation
No reputation score — basis not established for this investor.
No reputation sources on file yet.
Suggest a sourceContact
Published sources only
Published contact details collected from public sources. Not a referral, and not an introduction.
Published contact
- Website
- www.sanderling.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
Claimed profiles can replace or remove contact details.
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Fred Middleton. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewFirm-level reviews are not attributed to Fred Middleton.
Methodology
This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.
Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.
Corrections with a source: Suggest a correction.
Source record 1
- [1]
DATABASE · GlassVC catalog — Catalog record for Fred Middleton — provenance: GlassVC catalog
↩ cites: Title · Firm · Type · Bio · Location · Focus · Credited deals · Board seats
EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026
